Synthesis of 4-Dehydroxydiversonol
FULL PAPER
NH4Cl solution (5 mL). The mixture was poured into sat. aq NH4Cl solu-
tion (100 mL) and extracted with Et2O (3ꢅ50 mL). The combined organ-
ic layers were dried (Na2SO4) and concentrated in vacuo. Chromato-
graphic separation on silica gel (n-pentane/Et2O 95:5!8:2) provided the
title compound 7 (435 mg, 1.50 mmol, 83%) and the corresponding Z
isomer (73.1 mg, 252 mmol, 14%) as pale-yellow oils.
3375, 2939, 2855, 1618, 1586, 1463, 1353, 1231, 1109, 1023, 880, 814 cmꢀ1
;
UV/Vis (CH3CN): lmax (log e)=207.5 (4.635), 272.0 (2.954), 280.0 nm
(2.942); MS (ESI): m/z (%): 495.2 (27) [2M+Na+], 259.1 (100) [M+Na+],
237.2 (8) [M+H+]; HRMS (EI): m/z: calcd for [C14H20O3+Na+]:
259.1305; found: 259.1305.
(2S)-5-Methoxy-2,7-dimethyl-2-vinyl-chroman (24): PnBu3 (110 mL,
87.4 mg, 394 mmol) was added dropwise to a solution of alcohol 22
(46.6 mg, 197 mmol) and 2-nitrophenyl selenocyanate (23) (91.4 mg,
394 mmol) in THF (4.0 mL) at 08C. The resulting mixture was stirred at
08C for 1 h before being poured into sat. aq NaHCO3 solution (10 mL)
and extracted with Et2O (3ꢅ10 mL). The combined organic fractions
were dried (Na2SO4) and evaporated in vacuo. The residue was dissolved
in CH2Cl2 (4.0 mL), the solution was cooled to ꢀ408C, Na2HPO4
(175 mg, 985 mmol) and mCPBA (116 mg, 70% (w/w), 470 mmol) were
added and the resulting suspension was stirred at ꢀ408C for 1 h. After
addition of iPr2NH (140 mL, 99.7 mg, 985 mmol) the mixture was allowed
to reach RT, and stirring was continued for further 14 h before silica gel
(500 mg) was added. Evaporation of the solvent under reduced pressure
and column chromatography of the residue on silica gel (n-pentane/Et2O
98:2) yielded vinyl chroman 24 as a pale-yellow oil (37.7 mg, 173 mmol,
88%). Rf =0.42 (n-pentane/EtOAc 98:2); [a]2D0 =ꢀ52.7 (c=1.5 in
CHCl3); 1H NMR (300 MHz, CDCl3): d=1.42 (s, 3H; 2-CH3), 1.78 (ddd,
J=13.6, 9.8, 5.9 Hz, 1H; 3-Ha), 1.92 (ddd, J=13.6, 6.0, 5.0 Hz, 1H; 3-Hb),
2.31 (s, 3H; Ar-CH3), 2.46 (ddd, J=16.8, 9.8, 6.2 Hz, 1H; 4-Ha), 2.67 (dt,
J=16.8, 5.5 Hz, 1H; 4-Hb), 3.81 (s, 3H; OCH3), 5.07 (dd, J=10.8, 1.2 Hz,
1H; 2’-H), 5.20 (dd, J=17.4, 1.2 Hz, 1H; 2’-H), 5.88 (dd, J=17.4,
10.8 Hz, 1H; 1’-H), 6.25 (s, 1H; Ar-H), 6.39 ppm (s, 1H; Ar-H);
13C NMR (75 MHz, CDCl3): d=16.7 (C-4), 21.6 (Ar-CH3), 26.8 (2-CH3),
31.3 (C-3), 55.3 (OCH3), 76.2 (C-2), 102.6, 110.0 (C-6, C-8), 107.3 (C-4a),
113.6 (C-2’), 136.9 (C-7), 141.3 (C-1’), 154.3, 157.4 ppm (C-5, C-8a); IR
(film): n˜ =3088, 2976, 2936, 2852, 1619, 1586, 1463, 1353, 1232, 1140,
1024, 923, 813 cmꢀ1; UV/Vis (CH3CN): lmax (log e)=207.0 (4.665), 271.5
(2.995), 280.0 (2.976), 406.0 nm (1.956); MS (ESI): m/z (%): 219.1 (100)
[M+H+]; HRMS (EI): m/z: calcd for [C14H18O2+H+]: 219.1379; found:
219.1379.
Method
B (domino Wacker–Heck reaction of 8): A solution of
[Pd(OTFA)2] (8.3 mg, 24.7 mmol, 10 mol%) and (S,S)-Bn-BOXAX (17)
ACHTUNGTRENNUNG
(56.5 mg, 98.7 mmol, 40 mol%) in dichloroethane (0.15 mL) was stirred at
RT for 30 min before being treated with p-benzoquinone (107 mg,
987 mmol) and stirred for further 10 min. A solution of phenol 8 (51.0 mg,
247 mmol) and methyl acrylate (9) (111 mL, 106 mg, 1.23 mmol) in di-
chloroethane (0.15 mL) was added and the resulting mixture was stirred
at RT for 7 d. The slurry was poured into 1n HCl (10 mL) and the aque-
ous phase was extracted with Et2O (3ꢅ10 mL). The combined extracts
were washed with 1n NaOH (3ꢅ10 mL), dried (Na2SO4) and concentrat-
ed under reduced pressure. Column chromatography on silica gel afford-
ed the E-isomer 7 exclusively as a pale-yellow oil (39.4 mg, 136 mmol,
55%, 88% ee). Analytical data for the E-isomer 7: HPLC (column:
Daicel Chiralcel OD): wavelength: 272 nm, flow: 0.8 mLminꢀ1, eluent:
n-hexane/isopropanol 98:2, tR =13.7 min ((+)-7), 14.6 min ((ꢀ)-7); Rf =
0.28 (n-pentane/Et2O 9:1); [a]2D0 =+24.0 (c=1.0 in CHCl3); 1H NMR
(300 MHz, CDCl3): d=1.29 (s, 3H; 2-CH3), 1.74 (dt, J=13.8, 6.9 Hz, 1H;
3-Ha), 1.80 (dt, J=13.8, 6.9 Hz, 1H; 3-Hb), 2.28 (s, 3H; Ar-CH3), 2.47
(ddd, J=14.1, 7.8, 1.1 Hz, 1H; 4’-Ha), 2.53 (ddd, J=14.1, 7.8, 1.1 Hz, 1H;
4’-Hb), 2.60 (t, J=6.9 Hz, 2H; 4-H2), 3.74 (s, 3H; CO2CH3), 3.80 (s, 3H;
Ar-OCH3), 5.90 (dt, J=15.6, 1.1 Hz, 1H; 2’-H), 6.25 (s, 1H; Ar-H), 6.31
(s, 1H; Ar-H), 7.03 ppm (dt, J=15.6, 7.8 Hz, 1H; 3’-H); 13C NMR
(125 MHz, CDCl3): d=16.4 (C-4), 21.6 (Ar-CH3), 24.3 (2-CH3), 30.5 (C-
3), 42.2 (C-4’), 51.4 (CO2CH3), 55.3 (Ar-OCH3), 75.0 (C-2), 102.7, 110.4
(C-6, C-8), 106.7 (C-4a), 123.9 (C-2’), 137.2 (C-7), 144.3 (C-3’), 153.7,
157.6 (C-5, C-8a), 166.6 ppm (C-1’); IR (film): n˜ =2946, 2853, 1725, 1657,
1619, 1586, 1463, 1353, 1109, 815 cmꢀ1; UV/Vis (CH3CN): lmax (log e)=
207.5 (4.749), 271.0 (3.038), 280.0 nm (2.980); MS (ESI): m/z (%): 603.3
(37) [2M+Na+], 313.1 (100) [M+Na+], 291.2 (73) [M+H+]; HRMS
(EI): m/z: calcd for [C17H22O4+H+]: 291.1591; found: 291.1592. Analyti-
cal data for the Z isomer: Rf =0.34 (n-pentane/Et2O 9:1); [a]2D0 =+6.6
(c=0.5 in CHCl3); 1H NMR (300 MHz, CDCl3): d=1.27 (s, 3H; 2-CH3),
1.71–1.89 (m, 2H; 3-H2), 2.28 (s, 3H; Ar-CH3), 2.58 (dt, J=17.8, 6.7 Hz,
1H; 4-Ha), 2.66 (dt, J=17.8, 6.7 Hz, 1H; 4-Hb), 2.97 (ddd, J=15.8, 7.0,
1.7 Hz, 1H; 4’-Ha), 3.08 (ddd, J=15.8, 7.8, 1.7 Hz, 1H; 4’-Hb), 3.71 (s,
3H; CO2CH3), 3.80 (s, 3H; Ar-OCH3), 5.92 (dt, J=11.7, 1.7 Hz, 1H; 2’-
H), 6.24 (s, 1H; Ar-H), 6.31 (s, 1H; Ar-H), 6.47 ppm (dt, J=11.7, 7.4 Hz,
1H; 3’-H); 13C NMR (75 MHz, CDCl3): d=16.5 (C-4), 21.6 (Ar-CH3),
24.0 (2-CH3), 30.8 (C-3), 38.5 (C-4’), 51.0 (CO2CH3), 55.3 (Ar-OCH3),
75.1 (C-2), 102.7, 110.3 (C-6, C-8), 107.0 (C-4a), 121.1 (C-2’), 137.1 (C-7),
145.6 (C-3’), 154.0, 157.6 (C-5, C-8a), 166.8 ppm (C-1’); IR (film): n˜ =
2947, 2854, 1723, 1619, 1586, 1439, 1353, 1203, 1109, 814 cmꢀ1; UV/Vis
(CH3CN): lmax (log e)=207.5 (4.724), 209.0 (4.724), 271.0 (3.034),
280.0 nm (2.975); MS (ESI): m/z (%): 603.3 (16) [2M+Na+] 313.1 (100)
[M+Na+], 291.2 (63) [M+H+]; HRMS (EI): m/z: calcd for
[C17H22O4+H+]: 291.1591; found: 291.1591.
(2R)-4-(5-Methoxy-2,7-dimethyl-chroman-2-yl)-butyric acid methyl ester
(25): Pd/C (1.00 g, 10% Pd, 909 mmol) was added to a solution of unsatu-
rated ester 7 (2.64 g of an E/Z mixture, 9.09 mmol) in EtOAc (75 mL).
Hydrogen was passed through the resulting mixture for 30 min before
being stirred under a H2 atmosphere at RT for further 6 h. The catalyst
was removed by filtration over silica gel (eluting with EtOAc), and after
evaporation of the solvent in vacuo and column chromatography on silica
gel (n-pentane/Et2O 9:1) saturated ester 25 was obtained as a colourless
oil (2.60 g, 8.89 mmol, 98%). Rf =0.29 (n-pentane/Et2O 9:1); [a]2D0 =+7.6
(c=1.0 in CHCl3); 1H NMR (300 MHz, CDCl3): d=1.27 (s, 3H; 2-CH3),
1.55–1.66 (m, 2H), 1.67–1.87 (m, 6H; 3-H2, 3’-H2, 4’-H2), 2.27 (s, 3H; Ar-
CH3), 2.33 (m, 2H; 2’-H2), 2.59 (m, 2H; 4-H2), 3.66 (s, 3H; CO2CH3),
3.80 (s, 3H; Ar-OCH3), 6.23 (s, 1H; Ar-H), 6.28 ppm (s, 1H; Ar-H);
13C NMR (125 MHz, CDCl3): d=16.4 (C-4), 19.2 (C-3’), 21.6 (Ar-CH3),
23.8 (2-CH3), 30.4 (C-3), 34.2 (C-2’), 38.7 (C-4’), 51.4 (CO2CH3), 55.3
(Ar-OCH3), 75.3 (C-2), 102.4, 110.3 (C-6, C-8), 106.9 (C-4a), 136.9 (C-7),
154.1, 157.5 (C-5, C-8a), 173.9 ppm (C-1’); IR (film): n˜ =2948, 2731, 1739,
1618, 1586, 1462, 1353, 1110, 813 cmꢀ1; UV/Vis (CH3CN): lmax (log e)=
208.0 (4.636), 272.0 (2.943), 280.5 nm (2.932); MS (ESI): m/z (%): 607.3
(44) [2M+Na+], 315.2 (94) [M+Na+], 293.2 (100) [M+H+]; HRMS
(EI): m/z: calcd for [C17H24O4+Na+]: 315.1567; found: 315.1568.
(2S)-2-(5-Methoxy-2,7-dimethyl-chroman-2-yl)-ethanol (22): A solution
of ester 19 (253 mg, 957 mmol) in Et2O (3.0 mL) was added dropwise to
a suspension of LiAlH4 (40.0 mg, 1.05 mmol) in Et2O (3.0 mL) at 08C.
The resulting mixture was stirred at RT for 1 h before being carefully
quenched with water (10 mL). After separation of the organic layer the
aqueous phase was extracted with Et2O (3ꢅ10 mL). The combined or-
ganic phases were dried (Na2SO4) and the solvent evaporated in vacuo.
Column chromatography on silica gel (n-pentane/EtOAc 7:3) furnished
alcohol 22 as a colourless oil (221 mg, 935 mmol, 98%). Rf =0.28 (n-pen-
tane/EtOAc 7:3); [a]2D0 =ꢀ4.5 (c=1.0 in CHCl3); 1H NMR (300 MHz,
CDCl3): d=1.31 (s, 3H; 2-CH3), 1.68–2.05 (m, 4H; 2’-H2, 3-H2), 2.27 (s,
3H; Ar-CH3), 2.44 (t, J=4.9 Hz, 1H; OH), 2.50–2.63 (m, 1H; 4-Ha), 2.69
(dt, J=17.3, 6.0 Hz, 1H; 4-Hb), 3.77–3.99 (m, 2H; 1’-H2), 3.80 (s, 3H;
OCH3), 6.25 (s, 1H; Ar-H), 6.28 ppm (s, 1H; Ar-H); 13C NMR
(125 MHz, CDCl3): d=16.3 (C-4), 21.5 (Ar-CH3), 23.4 (2-CH3), 31.2 (C-
3), 41.8 (C-2’), 55.3 (OCH3), 59.0 (C-1’), 76.3 (C-2), 102.9, 110.3 (C-6, C-
8), 106.9 (C-4a), 137.1 (C-7), 153.5, 157.6 ppm (C-5, C-8a); IR (film): n˜ =
(2R)-4-(5-Methoxy-2,7-dimethyl-4-oxo-chroman-2-yl)-butyric acid methyl
ester (6)
Method A (Rh-catalysed oxidation): A solution of chroman 25 (300 mg,
1.03 mmol) and dirhodium-tetrakiscaprolactamate ([Rh2ACTHUNTRGNE(UGN cap)4], 26)
(3.4 mg, 5.15 mmol, 0.5 mol%) in dichloroethane (4.0 mL) was treated
with NaHCO3 (43.3 mg, 515 mmol). The reaction flask was sealed with a
septum and an empty balloon was attached by a needle to capture
oxygen generated during the reaction. tert-Butyl hydroperoxide (0.94 mL
of a 5.5m solution in decane, 5.17 mmol) was added and the resulting
deep-red solution was heated with stirring at 408C in a preheated oil
bath. After 3 h the mixture was treated with additional [Rh
2ACHTUNGTRENNUNG(cap)4]
(3.4 mg, 5.15 mmol) and tBuOOH (0.94 mL of a 5.5m solution in decane,
Chem. Eur. J. 2008, 14, 8956 – 8963
ꢃ 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
8961